bpc-157 fda warning human use not approved This is the first vote from the FDA's Pharmacy Compounding Advisory Committee on one of 7 peptides up for consideration. While the committee advises through these votes, ultimately the will make An FDA advisory panel will

The New York Public Service Commission's Order Modifying Medium- and Heavy-Duty Make-Ready Pilot Program of January, 2026 approved expansion of the participation eligibility in the MHD Pilot to include shared hub models, as well as allowing Participants without a voucher incentive to qualify for customer-side cost coverage

Rho kinase (ROCK) inhibitors in the management of corneal endothelial disease

On April 15, 2026, the FDA announced it is removing 12 peptides from Category 2, the list of bulk substances flagged as significant safety risks

But they are structurally unrelated molecules with different origins, different best-studied uses, and importantly different regulatory footprints

The aim is to improve: Sound hypersensitivity Noise-related anxiety Auditory processing difficulties Behavioural reactions to sound AIT is one type of sound therapy, considered a complementary autism treatment rather than a primary treatment like speech or behavioural therapy